Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenue, net $ 38,728 $ 46,926
Cost of revenue 14,598 17,001
Gross profit 24,130 29,925
Operating expenses:    
Sales and marketing 9,924 11,655
Research and development 642 676
General and administrative 9,480 9,486
Total operating expenses 20,046 21,817
Operating income from continuing operations 4,084 8,108
Interest accretion expense (34)
Note payable interest expense (168) (625)
Other expense, net (142) (499)
Income from continuing operations before tax 3,774 6,950
(Benefit) provision for income taxes (21,210) 4
Income from continuing operations 24,984 6,946
Loss from discontinued operations, net of tax (409) (244)
Net income 24,575 6,702
Less adjustment for preferred stock deemed dividend (464)
Net income attributable to common stockholders $ 24,575 $ 6,238
Basic net income (loss) per share of common stock:    
From continuing operations $ 5.65 $ 1.48
From discontinued operations (0.09) (0.06)
Net income (loss) per basic share of common stock 5.55 1.42
Diluted net income (loss) per share of common stock:    
From continuing operations 0.90 0.41
From discontinued operations (0.01) (0.02)
Net income (loss) per diluted share of common stock $ 0.89 $ 0.40
Weighted average number of common shares and common share equivalents outstanding:    
Basic 4,424 4,387
Diluted 27,695 15,734